Low-dose oral contraceptives can be used by a great number of women with ID
DM or a previous gestational diabetes mellitus. Others hormonal contracepti
ves (progestogen-only preparations) are less convenient and the compliance
is poor with an increasing risk of gynaecologic side effects. The safety of
this contraceptives as regards vascular diabetic complications is not eval
uated well.
Nulliparous patients with progressive complications can use barrier methods
of contraception after education. Macroprogestative contraception is a ade
quate choice for women within forties. For multiparous diabetic women, intr
a-uterine devices represent the first choice.